Abstract
Efficacy and safety of low-dose versus conventional-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected patients:A multi-centre, retrospective observational cohort study (RE-VISION-PCP)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have